Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia

European Respiratory Journal

Volumn 9, Issue 5, 1996, Pages 1006-1012

  Ewig, S ^a,b   Schafer H ^a   Rockstroh, J K ^a   Pickenhain, A ^a   Luderitz B ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Aerosolized pentamidine; human immunodeficiency virus; Pneumocystis carinii pneumonia; prophylaxis

Indexed keywords

PENTAMIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME;

EID: 0029899077     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09051006     Document Type: Article

References (30)

1. Hirschel B, Lazzarin A, Chopard P, et al., and the Swiss group for clinical studies on AIDS. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324: 1079-1083.
2. Jensen BN, Nielsen TL, Backer V, et al. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial. J Acquir Immune Defic Syndr 1993; 6: 472-477.
3. Montaner JS, Lawson LM, Gervais A, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study. Ann Intern Med 1991; 114: 948-953.
4. Bozzette SA, Finkelstein DM, Spector SA, et al., for the NIAID AIDS Clinical Trial Group. A randomized trial of three anti-pneumocystis agents in patients with advanced human immunodeficiency virus infection. N Eng J Med 1995; 332: 693-699.
5. Jules Elysee KM, Stover DE, Zaman MB, Bernard EM, White DA. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112: 750-757.
6. Levine SJ, Kennedy D, Shelhamer JH, et al. Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis. Am Rev Respir Dis 1992; 146: 838-843.
7. Baughman RP, Dohn MN, Shipley R, Buchsbaum JA, Frame PT. Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis. Chest 1993; 103: 426-432.
8. Fahy JV, Chin DP, Schnapp LM, et al. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia. Am Rev Respir Dis 1992; 146: 844-848.
9. Metersky ML, Catanzaro A. Diagnostic approach to Pneumocystis carinii pneumonia in the setting of prophylactic aerosolized pentamidine. Chest 1991; 100: 1345-1349.
10. Read CA, Cerrone F, Busseniers AE, Waldhorn E, Lavello JP, Pierce PF. Differential lobe lavage for diagnosis of acute Pneumocystis carinii pneumonia in patients receiving prophylactic aerosolized pentamidine therapy. Chest 1993; 103: 1520-1523.
11. Yung RC, Weinacker AB, Steiger DJ, et al. Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993; 148: 1563-1566.
12. Feuerstein IM, Archer A, Pluda JM, et al. Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation. Radiology 1990; 174: 697-702.
13. Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis and granulomas. Am J Surg Pathol 1990; 14: 615-625.
14. Seitz HM. Technik des mikrobiologischen Nachweises von Pneumocystis carinii. In: Dietrich M, ed. Die Pneumocystis carinii Pneumonie. Klinik, Diagnostik, Therapie, Prophylaxe. Springer Verlag, 1989; pp. 147-150.
15. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mor Mort Weekly Rep (CDC Surveillance Summer 1992), 36 RR-17: 1-19.
16. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Lange medical book. San Mateo, CA and Norwalk, CT, Prentice-Hall International Inc., 1990.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958; 53: 457-481.
18. Brenner M, Ognibene FP, Lark EE, et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1987; 136: 1199-1206.
19. Matthews WC, Ferdon E, Bennett C, Kanouse D. Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach. J Clin Epidemiol 1989; 42: 421-425.
20. Bennett CL, Weinstein RA, Shapiro MF, et al. A rapid preadmission method for predicting in-patient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1994; 150: 1503-1507.
21. Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia: diagnostic and prognostic significance. Am Rev Respir Dis 1988; 137: 796-800.
22. Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989; 139: 1336-1342.
23. Pretet S, Salmon D, Rousseau F, et al. Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients. Am J Med 1993; 94: 35-40.
24. Heffner JE, Harley RA, Schabel SI. Pulmonary reactions from illicit substance abuse. Clin Chest Med 1990; 11: 151-162.
25. DeLorenzo LJ, Huang CT, Maguire GP, Stone DJ. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987; 91: 323-327.
26. Ferrer C, Baguena F, Podzamczer D, et al. Lung cavitation associated with Pneumocystis carinii infection in the acquired immunodeficiency syndrome: a report of six cases and review of the literature. Eur Respir J 1994; 7: 134-139.
27. Chaffey MH, Klein JS, Gamsu G, Blanc P, Golden JA. Radiographie distribution of Pneumocystis carinii pneumonia in patients with AIDS treated with prophylactic inhaled pentamidine. Radiology 1990; 175: 715-719.
28. Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol 1993; 138: 952-964.
29. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994; 170: 198-202.
30. Chaisson RE, Keruly J, Richman DD, Moore RD. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine: the Zidovudine Epidemiology Group. Arch Intern Med 1992; 152: 2009-2013.